We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

31 hedge funds and large institutions have $2.94M invested in NKGen Biotech, Inc. Warrants in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

15% more funds holding

Funds holding: 27 → 31 (+4)

34% less capital invested

Capital invested by funds: $4.43M → $2.94M (-$1.49M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
1
Closed
1
Calls
$30K
Puts
–
Net Calls
+$30K
Net Calls Change
-$26K

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$83.2K
2
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$66.6K
3
FBCM
Fort Baker Capital Management
California
+$46.1K
4
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$33.3K
5
AA
Ancora Advisors
Ohio
+$166

Top Sellers

Rank Fund Capital Flow
1
NRCM
Northern Right Capital Management
Connecticut
-$35K
2
RCM
Rivernorth Capital Management
Florida
-$563
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.17M – – –
FBCM
2
Fort Baker Capital Management
California
$537K +$46.1K +55,398 New
HCM
3
Highbridge Capital Management
New York
$178K – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$110K – – –
AA
5
AQR Arbitrage
Connecticut
$79K – – –
PC
6
Periscope Capital
Ontario, Canada
$73K – – –
DCM
7
Difesa Capital Management
New York
$67K – – –
KC
8
Kepos Capital
New York
$64K – – –
6CM
9
683 Capital Management
New York
$61K – – –
FTCM
10
Fir Tree Capital Management
New York
$61K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
11
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$61K +$83.2K +100,000 New
SCC
12
Spring Creek Capital
Kansas
$56K – – –
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$49K – – –
PSAMP
14
P. Schoenfeld Asset Management (PSAM)
New York
$49K +$66.6K +80,000 New
TCA
15
Taconic Capital Advisors
New York
$42K – – –
PAMP
16
Polar Asset Management Partners
Ontario, Canada
$36K – – –
SCM
17
Shaolin Capital Management
Florida
$31K – – –
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$30K – – –
RCM
19
Rivernorth Capital Management
Florida
$24K -$563 -677 -2%
AIMCA
20
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$24K +$33.3K +40,000 New
JG
21
Jefferies Group
New York
$21.2K – – –
ACM
22
Atalaya Capital Management
New York
$18K – – –
CH
23
CVI Holdings
Delaware
$16K – – –
GF
24
Gabelli Funds
New York
$12K – – –
SC
25
Sculptor Capital
New York
$12K – – –
1
2

NKGNW Hedge Fund Activity: Q1 2022 in Review

31 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q1 2022, worth a combined $2.94M — down 34% from $4.43M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NKGNW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $83.2K. The largest seller was Northern Right Capital Management, exiting entirely with an estimated $35K sold.

  • 31 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q1 2022, up from 27 in Q4 2021.
  • Funds reported $2.94M of NKGen Biotech, Inc. Warrants stock for Q1 2022, down 34% quarter-over-quarter.
  • 5 funds opened new NKGen Biotech, Inc. Warrants positions in Q1 2022 and 1 closed out, a net change of +4 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $83.2K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q1 2022 was Northern Right Capital Management, an estimated $35K sold.

Based on aggregated 13F filings for Q1 2022.